| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.1M | — | +6.6% |
| Cost of Revenue | $19.1M | — | +10.3% |
| R&D Expense | $982K | — | +12.4% |
| SG&A Expense | $7.4M | — | +21.7% |
| Operating Income | -$982K | — | -248.3% |
| Pre-tax Income | -$842K | — | -514.8% |
| Income Tax | $0 | — | — |
| Net Income | -$842K | — | -514.8% |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.7M | -28.9% | -26.3% |
| Accounts Receivable | $16.0M | +6.5% | +3.8% |
| Inventory | $19.9M | +25.3% | -8.4% |
| Current Assets | $46.0M | +5.0% | -4.5% |
| Total Assets | $232.1M | +0.7% | -18.2% |
| Current Liabilities | $45.1M | +6.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $64K | — | +101.1% |
| Investing Cash Flow | -$754K | — | +79.0% |
| Financing Cash Flow | $1.5M | — | -23.5% |
| +4.9% |
| Long-term Debt | $30.4M | +5.9% | +12.2% |
| Total Liabilities | $64.3M | +2.7% | -1.8% |
| Stockholders' Equity | $167.8M | -0.1% | -23.1% |